Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H32O2 |
Molecular Weight | 316.4776 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC=C4C[C@@H](O)CC[C@]34C
InChI
InChIKey=ORNBQBCIOKFOEO-QGVNFLHTSA-N
InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/24084011https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82315Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18068870 |
https://www.ncbi.nlm.nih.gov/pubmed/24385629 |
https://www.ncbi.nlm.nih.gov/pubmed/21756978
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24084011https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82315
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18068870 |
https://www.ncbi.nlm.nih.gov/pubmed/24385629 |
https://www.ncbi.nlm.nih.gov/pubmed/21756978
Pregnenolone is an endogenous steroid and precursor the biosynthesis of most of the steroid hormones, including the progestogens, androgens, estrogens, glucocorticoids, and mineralocorticoids. In addition, pregnenolone is a precursor of neurosteroid pregnenolone sulfate, which is positive modulator of NMDA receptors and negative modulator of GABAA. Pregnenolone itself is a negative allosteric modulator of cannabinoid receptors. Pregnenolone is available as a dietary supplement, and is being investigated in clinical trials agains schizophrenia, bipolar disorder, major depressive disorder, marijuana dependency and other conditions.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24084011https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82315
Curator's Comment: As a precursor of neurosteroid, pregnenolone is endogenously produced in the brain.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24084011 |
7.2 µM [IC50] | ||
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1654510 |
33.0 µM [EC50] | ||
Target ID: Q7Z4N2|||Q7Z4N3 Gene ID: 4308.0 Gene Symbol: TRPM1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/24084011 |
|||
Target ID: Q9HCF6|||Q86SH6|||Q86Z01 Gene ID: 80036.0 Gene Symbol: TRPM3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/24084011 |
|||
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24385629 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | PREGNENOLONE Approved UsePregnenolone is a dietary supplement designed to promote mood and mental balance between body systems. Pregnenolone is a hormone similar to DHEA (dehydroepiandrosterone) and may be taken in addition to DHEA, or as an alternative. Pregnenolone is manufactured by many body tissues and under certain conditions, may be converted into similar substances, such as DHEA or progesterone. |
|||
Primary | PREGNENOLONE Approved UsePregnenolone is a dietary supplement designed to promote mood and mental balance between body systems. Pregnenolone is a hormone similar to DHEA (dehydroepiandrosterone) and may be taken in addition to DHEA, or as an alternative. Pregnenolone is manufactured by many body tissues and under certain conditions, may be converted into similar substances, such as DHEA or progesterone. |
|||
Primary | PREGNENOLONE Approved UsePregnenolone is a dietary supplement designed to promote mood and mental balance between body systems. Pregnenolone is a hormone similar to DHEA (dehydroepiandrosterone) and may be taken in addition to DHEA, or as an alternative. Pregnenolone is manufactured by many body tissues and under certain conditions, may be converted into similar substances, such as DHEA or progesterone. |
|||
Primary | PREGNENOLONE Approved UsePregnenolone is a dietary supplement designed to promote mood and mental balance between body systems. Pregnenolone is a hormone similar to DHEA (dehydroepiandrosterone) and may be taken in addition to DHEA, or as an alternative. Pregnenolone is manufactured by many body tissues and under certain conditions, may be converted into similar substances, such as DHEA or progesterone. |
|||
Primary | PREGNENOLONE Approved UsePregnenolone is a dietary supplement designed to promote mood and mental balance between body systems. Pregnenolone is a hormone similar to DHEA (dehydroepiandrosterone) and may be taken in addition to DHEA, or as an alternative. Pregnenolone is manufactured by many body tissues and under certain conditions, may be converted into similar substances, such as DHEA or progesterone. |
|||
Primary | PREGNENOLONE Approved UsePregnenolone is a dietary supplement designed to promote mood and mental balance between body systems. Pregnenolone is a hormone similar to DHEA (dehydroepiandrosterone) and may be taken in addition to DHEA, or as an alternative. Pregnenolone is manufactured by many body tissues and under certain conditions, may be converted into similar substances, such as DHEA or progesterone. |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
38 ng/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/15269827 |
600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered: |
CLOPIDOGREL plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
125.5 ng × h/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/15269827 |
600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered: |
CLOPIDOGREL plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1 h EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/15269827 |
600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered: |
CLOPIDOGREL plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Doses
Dose | Population | Adverse events |
---|---|---|
250 mg 2 times / day multiple, oral Highest studied dose Dose: 250 mg, 2 times / day Route: oral Route: multiple Dose: 250 mg, 2 times / day Sources: |
unhealthy, 22.5 years (range: 18.1–35.5 years) n = 12 Health Status: unhealthy Condition: Autism Spectrum Disorder Age Group: 22.5 years (range: 18.1–35.5 years) Sex: M+F Population Size: 12 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. | 2000 Jan |
|
Pregnenolone sulfate increases hippocampal acetylcholine release and spatial recognition. | 2000 Jan 3 |
|
Mechanism of action of noradrenaline on secretion of progesterone and oxytocin by the bovine corpus luteum in vitro. | 2001 |
|
Regulation of acute cortisol synthesis by cAMP-dependent protein kinase and protein kinase C in a teleost species, the rainbow trout (Oncorhynchus mykiss). | 2001 Apr |
|
Developmental changes in progesterone biosynthesis and metabolism in the quail brain. | 2001 Apr 13 |
|
Effects of different steroid-biosynthesis inhibitors on the testicular steroidogenesis of the toad Bufo arenarum. | 2001 Aug |
|
Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5 alpha-dihydroprogesterone in depressed patients during the latter half of pregnancy. | 2001 Dec |
|
Differential involvement of the sigma(1) (sigma(1)) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse. | 2001 Dec |
|
Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein. | 2001 Dec |
|
Diminished allopregnanolone enhancement of GABA(A) receptor currents in a rat model of chronic temporal lobe epilepsy. | 2001 Dec 1 |
|
The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. | 2001 Feb 14 |
|
Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity. | 2001 Jan |
|
The octadecaneuropeptide ODN stimulates neurosteroid biosynthesis through activation of central-type benzodiazepine receptors. | 2001 Jan |
|
Allopregnanolone, pregnenolone sulfate, and epitestosterone in breast cyst fluid. | 2001 Jan |
|
Leydig cell aging: steroidogenic acute regulatory protein (StAR) and cholesterol side-chain cleavage enzyme. | 2001 Jan-Feb |
|
Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome. | 2001 Jul |
|
Molecular modelling of 17 alpha-hydroxylase-17,20-lyase. | 2001 Jun |
|
Steroids in the nervous system: a Pandora's box? | 2001 Jun |
|
Leukemia inhibitory factor antagonizes gonadotropin induced-testosterone synthesis in cultured porcine leydig cells: sites of action. | 2001 Jun |
|
Progestins block cholesterol synthesis to produce meiosis-activating sterols. | 2001 Mar |
|
Follicle-stimulating hormone regulates steroidogenic enzymes in cultured cells of the chick embryo ovary. | 2001 Mar |
|
Distinct effect of pregnenolone sulfate on NMDA receptor subtypes. | 2001 Mar |
|
Enhanced dehydroepiandrosterone synthesis by amnion compared to chorion: a comparative study using the reverse-isotope dilution technique. | 2001 Mar |
|
Neurosteroid-induced enhancement of glutamate transmission in rat hippocampal slices. | 2001 Mar 30 |
|
[Effect of genotype and social stress on cAMP- and substrate-dependent mechanisms of regulating hormonal function of testis in mice]. | 2001 May |
|
Neurosteroids: recent findings. | 2001 Nov |
|
The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities. | 2001 Nov |
|
Anatomical and biochemical evidence for the synthesis of unconjugated and sulfated neurosteroids in amphibians. | 2001 Nov |
|
Immunoelectron microscopic localization of three key steroidogenic enzymes (cytochrome P450(scc), 3 beta-hydroxysteroid dehydrogenase and cytochrome P450(c17)) in rat adrenal cortex and gonads. | 2001 Nov |
|
Neuroactive steroids modulate crustacean locomotor activity. | 2001 Nov 2 |
|
Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain. | 2001 Oct |
|
Aldosterone increases T-type calcium currents in human adrenocarcinoma (H295R) cells by inducing channel expression. | 2001 Oct |
|
Activity and localization of 3beta-hydroxysteroid dehydrogenase/ Delta5-Delta4-isomerase in the zebrafish central nervous system. | 2001 Oct 22 |
|
Pregnenolone sulfate modulates angiotensin II-induced inositol 1,4,5-trisphosphate changes in the anterior pituitary of female rat. | 2001 Sep 28 |
|
Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway. | 2015 Mar 17 |
Sample Use Guides
In the model of schizophrenia, pregnenolone sulfate was administered to mice intraperitoneally at 40 or 60 mg/kg. When administered to rats intracerebroventricularly, 12 nmol but not 192 nmol pregnenolone sulfate enhanced spatial memory performance.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1654510
Activity with respect to NMDA and GABA uiion channels was measured using whole cell variant of the patch-clamp technique. Patch electrodes were fabricated with a double pull from thin-wall borosilicate glass microcapillary pipets. Electrode resistance was 5.2 ± 0.12 MOhm (n = 65) when filled with intracellular solution. After formation of a tight seal (typically 1-10 GOhm), capacitative transients were minimized. The patch of membrane under the pipet tip was then ruptured by gentle suction, to obtain the whole-cell configuration. Drug solutions were applied to single neurons by pressure ejection (15 psi) from seven-barrel pipets. Under these conditions, the drug solution in the pressure pipet rapidly and effectively replaces the solution surrounding the target neuron, with <10% dilution. In all experiments, neurons received a 10-sec prepulse of either external buffer or drug solution, followed by a 10-sec application of agonist, followed by a 10-20-sec pulse of external buffer solution.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
13894-1
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
||
|
CFR |
21 CFR 862.1615
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
||
|
NCI_THESAURUS |
C1636
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
||
|
LOINC |
17480-5
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
||
|
DSLD |
1868 (Number of products:84)
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
||
|
CFR |
21 CFR 310.530
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
||
|
LOINC |
25507-5
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
||
|
LOINC |
2837-3
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2105373
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
73R90F7MQ8
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
1616
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
m9121
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
145-13-1
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
73R90F7MQ8
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
SUB10024MIG
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
DTXSID1036541
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
2376
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
DB02789
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
205-647-4
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
Pregnenolone (medication)
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
D011284
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
4178
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
114052
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | RxNorm | ||
|
16581
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
18158
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
100000081407
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
8955
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
PREGNENOLONE
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY | |||
|
C82315
Created by
admin on Sat Dec 16 17:13:51 GMT 2023 , Edited by admin on Sat Dec 16 17:13:51 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (METABOLITE)